首页> 外文会议>International Conference on Medical and Biological Engineering >Use of Hollow Microneedle Drug Delivery Systems in Treatment of Diabetes Mellitus
【24h】

Use of Hollow Microneedle Drug Delivery Systems in Treatment of Diabetes Mellitus

机译:使用空心微针药物递送系统治疗糖尿病

获取原文

摘要

Use of microneedles as drug delivery systems provides a number of benefits to patients. Easier and simple drug use, reduced side effects, and incontinence are some of them. Microstock patch has been developing for the last few decades and they represent minimally invasive way for administration drugs in organism through the skin (transdermal administration). One of the approaches “poke with patch” uses microneedles to make holes (Hollow microneedles) and then apply a transdermal (TD) patch to the skin surface. TD drug delivery can improve compliance, minimize peaks, provide continuous drug administration and troughs in plasma levels during the day. These systems can take the place of more risky and invasive injection-based drug delivery (such as insulin injection). Objective of this paper is to research and present the application of hollow microneedles in treating diabetes and to compare it with conventional application of the drug. The drugs that we processed are metformin, insulin and exendin. Metformin is effective for treating diabetic patients therapeutically and preventively, maximizing the use of the current diabetes patch device. The main lack of conventional application of insulin is the fact that the application itself isn't optimal for a patient. TD1 showed significant improvement at level of absorption and bioavailability of the drug. New findings indicate that Exendin-4 diabetes microneedles can potentially replace the currently used subcutaneous (SC) injections because they can effectively reduce blood-glucose levels in patients with type 2 diabetes and are convenient to use.
机译:使用微针作为药物递送系统为患者提供了许多益处。更容易和简单的药物使用,减少副作用,尿失禁是其中一些。 MicroStock补丁在过去几十年中一直在发展,并且它们代表了通过皮肤(透皮给药)在生物体中的给药药物的微创方式。其中一个方法“用贴片”使用微针来制造孔(空心微针),然后将透皮(Td)贴片施加到皮肤表面。 TD药物递送可以改善顺应性,最小化峰,在白天提供连续的药物管理和血浆水平的槽。这些系统可以取代更危险和侵入性注射的药物递送(例如胰岛素注射)。本文的目的是研究和介绍中空微针在治疗糖尿病治疗中的应用,并将其与常规应用的药物进行比较。我们加工的药物是二甲双胍,胰岛素和exendin。二甲双胍对于治疗和预防性地治疗糖尿病患者是有效的,最大限度地利用当前糖尿病贴剂装置的使用。胰岛素的主要缺乏常规应用是申请本身对患者来说是最佳的。 TD1显示出对药物的吸收水平和生物利用度的显着改善。新发现表明,Exendin-4糖尿病微针可能会替代目前使用过的皮下(SC)注射,因为它们可以有效地降低2型糖尿病患者的血糖水平,并且可以方便使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号